Mel Barsky is a partner at CABHI Ventures. CABHI, led by Baycrest Health Sciences, helps innovators develop, disseminate, scale, and promote adoption of promising innovations in the aging and brain health sector. CABHI was formed as a unique private / public collaboration that raised over $124M and has levered an additional $70M+ for investing in validation testing in the brain health and longevity sector. To-date, CABHI has funded over 300 projects globally. CABHI innovators and companies have secured over $110M in follow on investments. Mel is leading the continued international growth of CABHI.
Prior to CABHI, Mel was Co-Founder, President & COO of INTERVENT Canada. INTERVENT has served over 2.5 million patients globally; over 200 corporations; and has been published in more than 100 peer reviewed major medical journals demonstrating the efficacy of its programs and improvement in health outcomes.
Previously, Mel was a Founding Partner and Executive Director of Scotiabank Private Equity Investments, where, he invested private and public ventures, primarily in financial services and information technology sectors.
In his spare time, Mel enjoys playing basketball, guitar and travelling with his wife, 5 kids and Australian Labradoodle.